Rosuvastatin Treatment Activates JAK-STAT Pathway and Increases Efficacy of Allogeneic Mesenchymal Stem Cell Transplantation in Infarcted Hearts - Concepedia

Concepedia

Publication | Open Access

Rosuvastatin Treatment Activates JAK-STAT Pathway and Increases Efficacy of Allogeneic Mesenchymal Stem Cell Transplantation in Infarcted Hearts

DOI Full Paper Access

63

Citations

38

References

2011

Year

Hui Xu, Yuejin Yang, Haiyan Qian, Yi‐Da Tang, Hong Wang, Qian Zhang

Circulation Journal

Abstract

ROSU treatment improves the efficacy of stem cell transplantation in infarcted hearts by activation of the JAK2-STAT3 signaling pathway.

References

	Year	Citations

Page 1